Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice (Q92508038)
Jump to navigation
Jump to search
scientific article published on 08 August 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice |
scientific article published on 08 August 2019 |
Statements
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice (English)
Elena Burova
Aynur Hermann
Jie Dai
Erica Ullman
Terra Potocky
Seongwon Hong
Matt Liu
Omaira Allbritton
Amy Woodruff
Jerry Pei
Ashique Rafique
William Poueymirou
Joel Martin
Douglas MacDonald
William C Olson
Andrew Murphy
Gavin Thurston